Glipizide
- Product NDC
- 51655-982
- 11-digit product format
- 516550982
- Labeler code
- 51655
- Product ID
- 51655-982_e04f1c5f-cd66-ff20-e053-2a95a90a3577
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Northwind Pharmaceuticals
- Application
- ANDA206928
- Marketing category
- ANDA
- Marketing start
- 2022-05-04
- Marketing end
- 0000-00-00
- Substance
- GLIPIZIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51655-982 | GLIPIZIDE TABLET, EXTENDED RELEASE [NORTHWIND PHARMACEUTICALS] | 2 | Legacy NDC | 20230404_e04f4a1f-face-c903-e053-2a95a90aab3f.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51655-982-26 | 51655098226 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-982-26) | 2022-05-04 | 0000-00-00 | No | No | Current |